The Medical College of Wisconsin has received a $44.9 million, six-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health and the National Cancer Institute to fund the Data and Coordinating Center (DCC) Consortium involved in supporting the Blood and Marrow Transplant Clinical Trials Network.
This grant is the largest in the Medical College’s history.
Mary Horowitz, M.D., M.S., is the primary investigator of the project. Horowitz is the Robert A. Uihlein, Jr. Professor in Hematologic Research and a professor of medicine in hematology and oncology at the Medical College of Wisconsin. She also is the chief scientific director of the Center for International Blood and Marrow Transplant Research (CIBMTR), which is housed at the Medical College of Wisconsin.
The DCC Consortium, which is comprised of the CIBMTR, the National Marrow Donor Program and the EMMES Corp., supports the clinical trials network by developing, prioritizing and managing high-quality clinical trials for the network.
The CIBMTR offers a unique resource of data and statistical expertise to the scientific community.
The data, along with the analytic support offered by the CIBMTR, allows the Clinical Trials Network to complete high-quality clinical trials that focus on the most important barriers to transplant success.
“We have created the opportunity for greatly expanded global collaboration in data exchange, and contributed substantially to the success of a multicenter clinical trials network in blood and bone marrow transplantation,” Horowitz said.
Joseph Kerschner, M.D., interim dean and executive vice president of the Medical College, said, “The CIBMTR is unique in what it offers to researchers and clinicians all over the world. The data we offer provides the very best information for safety, efficacy, best practices, and best patient outcomes. This allows us to continue to grow that knowledge bank, to measure the success of our current treatments, and evaluate new therapies.”